Page 174 - pharma 1 theoretical updated MNU_Neat
P. 174
Clinical pharmacy 2024/2025 Level 3 Pharm D Pharmacology 1 (PO 502)
2- Inhibition of cytochrome P450 → interfere with the metabolism of drugs such as
phenytoin, tolbutamide, warfarin, fluvastatin and tamoxifen if taken concomitantly.
3- Serious hematological adverse effects “neutropenia, thrombocytopenia, and
aplastic anemia) limit ticlopidine usefulness.
| P a g e 158